Petros Grivas, MD, PhD, discusses the overall survival and quality-of-life findings from the JAVELIN Bladder 100 trial of ...
CG Oncology Inc. (NASDAQ:CGON) is one of the best hot stocks to invest in. On October 8, Guggenheim analyst Brad Canino ...
Discover the most anticipated abstracts on renal cell carcinoma and bladder cancer at the 2025 ESMO Congress in Berlin. With the 2025 European Society of Medical Oncology (ESMO) Congress starting on ...
A phase 2 trial evaluated the combination of neoadjuvant pembrolizumab and accelerated methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in patients with nonurothelial bladder cancers ...
When the organization now called the European Society for Medical Oncology (ESMO) opens its 50th anniversary Congress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback